[Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome].
D000368:Aged; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004077:Digoxin / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D011217:Practolol / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications*
D004077:Digoxin; D008012:Lidocaine; D011342:Procainamide; D011217:Practolol
Controindicazioni all'impiego della digitale nella fibrillazione atriale in corso di W.P.W